Skip to main content
SpringerLink
Log in

Anagrelide

Anaemia and lower leg oedema: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ito T, et al. Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naive essential thrombocythemia patients in a real-world setting. European Journal of Haematology 103: 116-123, No. 2, Aug 2019. Available from: URL: http://doi.org/10.1111/ejh.13265 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anagrelide. Reactions Weekly 1768, 40 (2019). https://doi.org/10.1007/s40278-019-66725-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-66725-8

Search

Navigation